← Eichor
Condition: Systemic Sclerosis Pulmonary Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Systemic Sclerosis Pulmonary

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Home-Based Clinical Management of Cardiac Complications in Systemic Sclerosis
Phase N/A · 1 location(s) · Oslo University Hospital · NCT06865118Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases
NA · 1 location(s) · Oslo University Hospital · NCT06732674Evaluation of HRCT Patterns in Systemic Sclerosis-associated Interstitial Lung Disease
Phase N/A · 1 location(s) · Central Hospital, Nancy, France · NCT05482607Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH.
Phase 1/Phase 2 · 1 location(s) · Beijing GoBroad Hospital · NCT06947473New Orleans Pulmonary Hypertension Biobank
Phase N/A · 1 location(s) · Louisiana State University Health Sciences Center in New Orl · NCT03269630ILD-SARDs Registry and Biorepository
Phase N/A · 1 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT05007340Deployment o the Multidisciplinary Prospective Cohort Imminent
NA · 1 location(s) · University Hospital, Lille · NCT04334031Sildenafil for Early Pulmonary Vascular Disease in Scleroderma
Phase 2 · 2 location(s) · Johns Hopkins University · NCT04797286Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Relate
Phase 2 · 15 location(s) · aTyr Pharma, Inc. · NCT05892614Multicenter Study on the Development of Pulmonary Arterial Hypertension Screening Models Based on Artificial Intelligenc
Phase N/A · 5 location(s) · Alejandro Cruz Utrilla · NCT07236970A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Ass
Phase 3 · 10 location(s) · GlaxoSmithKline · NCT06716606A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, a
Phase 2 · 4 location(s) · Changchun GeneScience Pharmaceutical Co., Ltd. · NCT06189495A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
Phase 2 · 26 location(s) · Deciphera Pharmaceuticals, LLC · NCT06619561Evaluation of Efficacy and Safety of Rituximab and Mycophenolate Mofetil Combination in Patients With Interstitial Lung
Phase 3 · 1 location(s) · University Hospital, Tours · NCT06549231Connective Tissue Diseases and Lung Manifestations
Phase N/A · 1 location(s) · Medical University Innsbruck · NCT04095351Platform Clinical Study for Conquering Scleroderma
Phase 2 · 34 location(s) · Scleroderma Research Foundation, Inc. · NCT06195072Hormonal, Metabolic, and Signaling Interactions in PAH
Phase N/A · 1 location(s) · Vanderbilt University Medical Center · NCT01884051Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
Phase N/A · 1 location(s) · Weill Medical College of Cornell University · NCT01776398Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease
Phase 3 · 1 location(s) · National Institute of Geriatrics, Rheumatology and Rehabilit · NCT06297096Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT06350110CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH
Phase 1/Phase 2 · 1 location(s) · Beijing GoBroad Hospital · NCT06947460Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
Phase 4 · 2 location(s) · University of Sao Paulo General Hospital · NCT07087912A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Phase 2/Phase 3 · 131 location(s) · GlaxoSmithKline · NCT05878717A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
Phase 2 · 3 location(s) · Galderma R&D · NCT07047690Interstitial Lung Disease Trajectories in Patients With Systemic Sclerosis
Phase N/A · 1 location(s) · Central Hospital, Nancy, France · NCT05345795Western Sweden Systemic Sclerosis Project
Phase N/A · 1 location(s) · Sahlgrenska University Hospital · NCT07345052Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease
Phase 2 · 3 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT05785065Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Di
Phase 1/Phase 2 · 2 location(s) · M.D. Anderson Cancer Center · NCT06434363Skeletal Muscle Function in Interstitial Lung Disease
NA · 1 location(s) · University of British Columbia · NCT03800017Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
Phase 2 · 3 location(s) · Paul Szabolcs · NCT03630211
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.